Feinstein A R, Wells C K
Am Heart J. 1977 Feb;93(2):172-82. doi: 10.1016/s0002-8703(77)80308-6.
The treatment of patients with angina pectoris is commonly evaluated according to such indexes as the frequency of anginal attacks, quantity of supplemental nitroglycerin, and exercise performance in an ergometric laboratory test. None of these indexes demonstrates the clinical change in ordinary functional limitations that may have been the major reason why a patient sought medical help. The New York Heart Association ratings of functional capacity do not refer to different types of activity and the four categories of the scale are too coarse to show distinct changes that can occur while a patient retains the same rating. A new taxonomy has been devised for rating transitions in functional capacity as noted in three different kinds of functional performance: occupation, customary activities, and sporadic activities. The ratings of change in these three activities can be combined into single global rating. When applied to conventional questionaire data for 309 patients in a randomized double-blind therapeutic trial, the new classifications showed a statistically significant superiority, in each type of functional transition and in the global ratings, for patients receiving timolol maleate rather than placebo. By augmenting the conventional information used for therapeutic evaluation, the new taxonomic indexes can expand the scientific scope of antianginal treatment. Data derived from history-taking can be just as statistically significant as "harder" forms of information, while simultaneously being more pertinent for the clinical challenge of choosing and evaluating the agents used in patient care.
通常根据诸如心绞痛发作频率、硝酸甘油补充量以及运动耐力实验室测试中的运动表现等指标来评估心绞痛患者的治疗情况。这些指标均未表明普通功能受限方面的临床变化,而这可能是患者寻求医疗帮助的主要原因。纽约心脏协会的功能能力分级并未涉及不同类型的活动,且该分级的四个类别过于粗略,无法显示出患者保持相同分级时可能发生的明显变化。针对在职业、日常活动和偶尔活动这三种不同功能表现中所观察到的功能能力转变,已设计出一种新的分类法进行分级。这三种活动变化的分级可合并为单一的总体分级。在一项随机双盲治疗试验中,将新分类法应用于309例患者的常规问卷调查数据时,对于接受马来酸噻吗洛尔而非安慰剂治疗的患者,在每种功能转变类型以及总体分级方面,新分类法均显示出统计学上的显著优势。通过增加用于治疗评估的常规信息,新的分类指标能够扩大抗心绞痛治疗的科学范畴。源自病史采集的数据在统计学上与“更确凿”的信息形式具有同样的显著性,同时对于选择和评估用于患者护理的药物这一临床挑战而言更具相关性。